SamaCare, a cloud-based patient access platform provider for specialty drugs with headquarters in San Francisco, California, has secured $17 million in Series B investment.
Investors
- Questa Capital
- South Park Commons
- Vive Collective
Use of funds
The money will be used by the business to quicken the development of its one-stop patient access platform’s products.
About SamaCare
SamaCare, led by CEO and Founder Syam Palakurthy, offers medical practitioners a cloud-based workflow automation platform to expedite specialty medicine prior authorization, enrollment, and benefit verification. The technology is used by pharmaceutical makers, providers, payors, and other stakeholders. Furthermore, it provides pharmaceutical companies with premium services and data analytics to enhance therapeutic accessibility.
SamaCare now services practices in neurology, rheumatology, cancer, and retina that together spend over $20 billion annually on specialty drugs and are still expanding rapidly.
